SCHEMBL31240668

SCHEMBL31240668

Cc1ccc(CC(=O)Nc2cc(Cl)ccn2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIOK2 Q9BVS4 4/20 0.67
MAPK10 P53779 3/20 0.67
GSK3A P49840 2/20 0.67
RAB9A P51151 4/20 0.65
SMN1; SMN2 Q16637 3/20 0.61
KMT2A Q03164 2/20 0.61
MEN1 O00255 1/20 0.61
ALDH1A1 P00352 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
POLB P06746 1/20 0.58
GAPDH P04406 1/20 0.57
MAPK8 P45983 1/20 0.56
HIPK1 Q86Z02 1/20 0.56
SNRK Q9NRH2 1/20 0.56
WNT3A P56704 2/20 0.55
NPC1 O15118 1/20 0.53
LOXL2 Q9Y4K0 1/20 0.53
RORC P51449 1/20 0.53
NR3C2 P08235 1/20 0.51
ANO1 Q5XXA6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240659 0.86 RIOK2 (0.74) RIOK2MAPK10GSK3ARAB9AKMT2A
SCHEMBL31240699 0.85 MAPK10 (0.75) RIOK2MAPK10GSK3ASMN1; SMN2KMT2A
SCHEMBL31240719 0.85 MAPK10 (0.66) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2
SCHEMBL31240684 0.85 RIOK2 (0.62) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2
SCHEMBL31240607 0.84 MAPK10 (0.61) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2
SCHEMBL31240713 0.83 RIOK2 (0.62) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2
SCHEMBL31240609 0.79 RIOK2 (0.61) RIOK2MAPK10GSK3ARAB9AKMT2A
SCHEMBL31240626 0.78 GSK3A (0.60) RIOK2MAPK10GSK3ARAB9AKMT2A
SCHEMBL31240687 0.78 RIOK2 (0.67) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2
SCHEMBL31240658 0.77 RIOK2 (0.65) RIOK2MAPK10GSK3ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 WO disclosed